A guide to UFMylation, an emerging posttranslational modification
The FEBS Journal · 2023-11 · 290 (21) · 5040-5056
DOI: 10.1111/febs.16730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 08.02.2023. Verfasst von David Millrine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Protein Phosphorylation & Ubiquitylation Unit (MRC-PPU), School of Life Sciences, University of Dundee, UK. Hauptthemen laut MEDLINE: Proteins, Protein Processing, Post-Translational. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Biotechnology and Biological Sciences Research Council, NIH HHS.
Abstract (Originalsprache)
Ubiquitin Fold Modifier‐1 (UFM1) is a ubiquitin‐like modifier (UBL) that is posttranslationally attached to lysine residues on substrates via a dedicated system of enzymes conserved in most eukaryotes. Despite the structural similarity between UFM1 and ubiquitin, the UFMylation machinery employs unique mechanisms that ensure fidelity. While physiological triggers and consequences of UFMylation are not entirely clear, its biological importance is epitomized by mutations in the UFMylation pathway in human pathophysiology including musculoskeletal and neurodevelopmental diseases. Some of these diseases can be explained by the increased endoplasmic reticulum (ER) stress and disrupted translational homeostasis observed upon loss of UFMylation. The roles of UFM1 in these processes likely stem from its function at the ER where ribosomes are UFMylated in response to translational stalling. In addition, UFMylation has been implicated in other cellular processes including DNA damage response and telomere maintenance. Hence, the study of UFM1 pathway mechanics and its biological function will reveal insights into fundamental cell biology and is likely to afford new therapeutic opportunities for the benefit of human health. To this end, we herein provide a comprehensive guide to the current state of knowledge of UFM1 biogenesis, conjugation, and function with an emphasis on the underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Council Protein Phosphorylation & Ubiquitylation Unit (MRC-PPU), School of Life Sciences, University of Dundee, UK.
ORCID-Profile: David Millrine, Joshua J Peter, Yogesh Kulathu
Förderung
- NIGMS NIH HHS
- Biotechnology and Biological Sciences Research Council
- NIH HHS
- Medical Research Council
- Lister Institute of Preventive Medicine
- Medical Research Council Canada
- National Institutes of Health
Zitieren
APA
Millrine, D., Peter, J. J., & Kulathu, Y. (2023). A guide to UFMylation, an emerging posttranslational modification. The FEBS Journal, 290(21), 5040-5056. https://doi.org/10.1111/febs.16730
Vancouver
Millrine D, Peter JJ, Kulathu Y. A guide to UFMylation, an emerging posttranslational modification. The FEBS Journal. 2023;290(21):5040-5056. doi:10.1111/febs.16730
BibTeX
@article{Millrine2023,
author = {Millrine, David and Peter, Joshua J and Kulathu, Yogesh},
title = {A guide to UFMylation, an emerging posttranslational modification},
journal = {The FEBS Journal},
year = {2023},
volume = {290},
number = {21},
pages = {5040--5056},
doi = {10.1111/febs.16730}
}
EUVIMED